Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosis L Ferrè, A Mogavero, F Clarelli, L Moiola, F Sangalli, B Colombo, ... Multiple Sclerosis Journal 27 (9), 1374-1383, 2021 | 7 | 2021 |
First-line immunotherapy in non-small cell lung cancer: how to select and where to go A Mogavero, O Cantale, V Mollica, S Anpalakhan, A Addeo, G Mountzios, ... Expert Review of Respiratory Medicine 17 (12), 1191-1206, 2023 | 5 | 2023 |
Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes A Mogavero, P Bironzo, L Righi, A Merlini, F Benso, S Novello, F Passiglia Life 13 (6), 1291, 2023 | 5 | 2023 |
Guideline-based follow-up outcomes in patients with gastrointestinal stromal tumor with low risk of recurrence: a report from the Italian Sarcoma Group L D’Ambrosio, E Fumagalli, TM De Pas, M Nannini, A Bertuzzi, S Carpano, ... JAMA Network Open 6 (11), e2341522-e2341522, 2023 | 4 | 2023 |
Assessing the role of colonic and other anatomical sites uptake by [18F]FDG‐PET/CT and immune‐inflammatory peripheral blood indexes in patients with … A Rizzo, O Cantale, A Mogavero, L Garetto, M Racca, T Venesio, ... Thoracic Cancer 14 (24), 2473-2483, 2023 | 3 | 2023 |
From Cancer to Immune Organoids: Innovative Preclinical Models to Dissect the Crosstalk between Cancer Cells and the Tumor Microenvironment F Picca, C Giannotta, J Tao, L Giordanengo, HMW Munir, V Botta, ... International Journal of Molecular Sciences 25 (19), 10823, 2024 | 1 | 2024 |
Comparison of NRS-2002 and MST nutritional screening and correlation with quality of life items in lung cancer patients (REAL-TIME observation study) S Carnio, O Cantale, I Capizzi, I Stura, A Nepote, A Samuelly, G Bernardi, ... | | 2024 |
Pleural empyema due to Salmonella enterica in a patient affected by lung adenocarcinoma: A clinical case report O Cantale, A Mogavero, S Carnio, LT Consito, C Mecca, F Passiglia, ... | | 2023 |
Growth rate and site of pulmonary metastasis to predict lung relapse and overall survival in patients affected by bone and soft tissue sarcomas (B-STS). L D'ambrosio, F Tolomeo, MC Bruna, S Aliberti, A Merlini, G Manessi, ... Journal of Clinical Oncology 39 (15_suppl), 11571-11571, 2021 | | 2021 |
Prognostic parameters of medium-term response to fingolimod treatment in Relapsing Remitting Multiple Sclerosis patients L Ferrè, F Clarelli, A Mogavero, M Romeo, L Moiola, F Sangalli, ... MULTIPLE SCLEROSIS JOURNAL 25, 793-793, 2019 | | 2019 |
Disease activity following fingolimod withdrawal in relapsing remitting multiple sclerosis: a monocentric Italian study F Esposito, L Ferre, F Clarelli, A Mogavero, M Romeo, B Colombo, ... EUROPEAN JOURNAL OF NEUROLOGY 26, 166-166, 2019 | | 2019 |